Metraipolis › archive › dc_b87bb7a368f6
Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for… — Europe PMC PMID:42558582
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42558582
- DOI
- 10.3389/fmed.2026.1896433
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T23:06:44.085Z
- SHA-256 of the archived text
dc4f2fc0151ec6e82e36bfdf5941233bbaa2d5ded72cac5642e2359b95fb0cb1- Stable URL of this page
https://metraipolis.com/documento/dc_b87bb7a368f6
How to cite
Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for… — Europe PMC PMID:42558582 — Europe PMC (en), https://europepmc.org/article/MED/42558582 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b87bb7a368f6 (Metraipolis archive dc_b87bb7a368f6, sha256 dc4f2fc0151ec6e82e36bfdf5941233bbaa2d5ded72cac5642e2359b95fb0cb1)
BibTeX
@misc{dcb87bb7a368f6,
title = {Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for… — Europe PMC PMID:42558582},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42558582},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b87bb7a368f6; sha256 dc4f2fc0151ec6e82e36bfdf5941233bbaa2d5ded72cac5642e2359b95fb0cb1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42558582. Agents can read the archived copy with the MCP tool read_document.